Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-034
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on Resolutions of the Fifth Meeting of the Fifth Board of Directors
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the company") The fifth meeting of the fifth board of directors was held on September 3, 2013 by means of communication and on-site voting. The meeting notice was written on August 26, 2013. E-mails, etc., the meeting should be attended by 7 directors, 7 actual attendees, and independent director Li Fei voted by way of communication. The convening of this meeting is in line with the relevant provisions of the Company Law and the Articles of Association. The convening procedures and voting results of this meeting are legal and valid.
After careful consideration by the attending directors, the following proposals were passed:
Reviewed and passed the "Proposal on the Establishment of Jilin Zhongke Zixin Technology Co., Ltd."
The result of the review: 7 votes in favor, 0 votes against, and 0 abstentions.
The company will set up a wholly-owned subsidiary, Jilin Zhongke Zixin Technology Co., Ltd., in Changchun City, Jilin Province with its own funds of 20 million yuan, and authorize Mr. Yin Jinlong to handle related matters related to industrial and commercial registration, tax registration and other related subsidiaries:
Place of registration: No. 137, Dongtou Road, Nanguan District, Changchun City, Jilin Province
Legal representative: Yin Jinlong
Registered capital: 20 million yuan
Business scope: development, production and sales of sequencer; gene sequencing.
The above business scope is ultimately subject to the business license approved by the administrative department for industry and commerce.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
September 4, 2013